Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

EBCC 2014 key messages to doctors

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes

Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK
Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes ( Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK )
1 Apr 2014

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

Regular physical activity reduces breast cancer risk irrespective of age

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Regular physical activity reduces breast cancer risk irrespective of age ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
31 Mar 2014

Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes

Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )
31 Mar 2014

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany
Toll like receptor 7 agonists for cancer immunotherapy ( Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany )
25 Mar 2014

Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703

Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg, Germany
Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703 ( Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg, Germany )
25 Mar 2014

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014

Reasons for combining immunotherapy with chemo to enhance anti tumour response

Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014

High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology

Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014